LIN SUE-JEAN

Track

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
LIN SUE-JEAN's trades of Arcutis Biotherapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
364.05
Quantity 78,579
Value US$1,157,468
Transaction date
Proposed sale
Price
30.78
Quantity 25,272
Value US$777,956
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-15
PlS Planned sale
69,793 +47.5%
455.82
US$3,632,316 		69,793 +47.5% 455.82 US$3,632,316
2026-06-15 2026-06-15
PrS Proposed sale
78,579
364.05
US$1,157,468 		78,579 364.05 US$1,157,468
2025-11-25 2025-11-24
S Sale
50,253 +24.3%
71.40
US$4,334,194 		50,253 +24.3% 71.40 US$4,334,194
2025-11-24 2025-11-24
PrS Proposed sale
25,272
30.78
US$777,956 		25,272 30.78 US$777,956